Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Augmedix, Inc. Common Stock (AUGX)

Services-business Services, Nec

https://www.augmedix.com

Augmedix Inc is engaged in ambulatory/clinical/hospital segments of the U.S. patient care services market with products that address medical note documentation needs. The company's products cater to large and small healthcare organizations but can also be adopted by individual practitioners. The company's revenues consist of service fees charged to its customers to subscribe to the company's remote medical documentation and clinical support products.

111 SUTTER STREET, SUITE 1300
SAN FRANCISC, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/04/2021

Market Cap

112,029,531

Shares Outstanding

47,620,000

Weighted SO

48,555,216

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

INAB --.--%

DRMA --.--%

ELEV --.--%

UTRS --.--%

ACON --.--%

Beta

-0.1890

Last Div

0.0000

Range

0.73-6.25

Chg

0.0050

Avg Vol

1026574

Mkt Cap

112029531

Exch

NASDAQ

Country

US

Phone

888 669 4885

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

2.1719

EV Multiple

-4.8021

P/FV

11.5960

Div Yield %

0.0000

P/E

-5.0931

PEG

-0.1499

Payout

0.0000

Current Ratio

1.6639

Quick Ratio

1.6639

Cash Ratio

1.1761

DSO

65.4682

DIO

0.0000

Op Cycle

65.4682

DPO

12.0391

CCC

53.4291

Gross Margin

0.4822

Op Margin

-0.4629

Pretax Margin

-0.4627

Net Margin

-0.4623

Eff Tax Rate

-0.0028

ROA

-0.4443

ROE

-1.8236

ROCE

-0.8046

NI/EBT

0.9992

EBT/EBIT

0.9995

EBIT/Rev

-0.4629

Debt Ratio

0.4094

D/E

2.0978

LT Debt/Cap

0.5974

Total Debt/Cap

0.6772

Int Coverage

1193.8500

CF/Debt

-0.7005

Equity Multi

5.1243

Rec Turnover

5.5752

Pay Turnover

30.3178

Inv Turnover

0.0000

FA Turnover

6.6437

Asset Turnover

0.9611

OCF/Share

-0.2883

FCF/Share

-0.3362

Cash/Share

0.5286

OCF/Sales

-0.2984

FCF/OCF

1.1663

CF Coverage

-0.7005

ST Coverage

-2.3929

CapEx Coverage

-6.0121

Div&CapEx Cov

-6.0121

P/BV

11.5960

P/B

11.5960

P/S

2.1719

P/E

-5.0931

P/FCF

-6.2409

P/OCF

-7.8914

P/CF

-7.8914

PEG

-0.1499

P/S

2.1719

EV Multiple

-4.8021

P/FV

11.5960

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Sep 12, 21:59 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CNOB, AUGX on Behalf of Shareholders GlobeNewswire Inc. Sep 07, 15:52 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FYBR, FLIC, GATO, AUGX on Behalf of Shareholders GlobeNewswire Inc. Dec 13, 10:05 Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation GlobeNewswire Inc. Nov 16, 00:15 Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock GlobeNewswire Inc. Nov 16, 00:15 Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock GlobeNewswire Inc. Nov 16, 00:15 Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock GlobeNewswire Inc. Nov 16, 00:15 Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock GlobeNewswire Inc. Nov 16, 00:15 Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock

Revenue Product Segmentation